Suheung Co., Ltd. (008490.KS)
KRW 14250.0
(9.45%)
KRW 14250.0
(9.45%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 467.85 Billion KRW | 15.61% |
| 2022 | 404.67 Billion KRW | 17.98% |
| 2021 | 342.99 Billion KRW | -1.42% |
| 2020 | 347.94 Billion KRW | 8.08% |
| 2019 | 321.93 Billion KRW | 17.76% |
| 2018 | 273.38 Billion KRW | 11.3% |
| 2017 | 245.62 Billion KRW | -2.2% |
| 2016 | 251.16 Billion KRW | -0.57% |
| 2015 | 252.59 Billion KRW | 14.11% |
| 2014 | 221.35 Billion KRW | 3.3% |
| 2013 | 214.29 Billion KRW | -6.56% |
| 2012 | 229.34 Billion KRW | 15.74% |
| 2011 | 198.15 Billion KRW | 51.22% |
| 2010 | 131.03 Billion KRW | 34.04% |
| 2009 | 97.76 Billion KRW | -4.98% |
| 2008 | 102.88 Billion KRW | 42.52% |
| 2007 | 72.19 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 473.06 Billion KRW | 1.11% |
| 2024 Q2 | 476.59 Billion KRW | 0.75% |
| 2023 FY | 467.85 Billion KRW | 15.61% |
| 2023 Q4 | 467.85 Billion KRW | -2.45% |
| 2023 Q1 | 434.54 Billion KRW | 7.38% |
| 2023 Q3 | 479.61 Billion KRW | 4.53% |
| 2023 Q2 | 458.84 Billion KRW | 5.59% |
| 2022 Q1 | 388.26 Billion KRW | 13.2% |
| 2022 FY | 404.67 Billion KRW | 17.98% |
| 2022 Q4 | 404.67 Billion KRW | -1.4% |
| 2022 Q3 | 410.44 Billion KRW | 7.75% |
| 2022 Q2 | 380.92 Billion KRW | -1.89% |
| 2021 FY | 342.99 Billion KRW | -1.42% |
| 2021 Q1 | 347.47 Billion KRW | -0.13% |
| 2021 Q3 | 362.54 Billion KRW | 6.41% |
| 2021 Q4 | 342.99 Billion KRW | -5.39% |
| 2021 Q2 | 340.69 Billion KRW | -1.95% |
| 2020 Q3 | 348.99 Billion KRW | -0.01% |
| 2020 Q2 | 349.04 Billion KRW | 6.61% |
| 2020 Q1 | 327.4 Billion KRW | 1.7% |
| 2020 FY | 347.94 Billion KRW | 8.08% |
| 2020 Q4 | 347.94 Billion KRW | -0.3% |
| 2019 Q4 | 321.93 Billion KRW | -1.17% |
| 2019 FY | 321.93 Billion KRW | 17.76% |
| 2019 Q3 | 325.75 Billion KRW | -4.47% |
| 2019 Q2 | 341 Billion KRW | 16.4% |
| 2019 Q1 | 292.96 Billion KRW | 7.16% |
| 2018 FY | 273.38 Billion KRW | 11.3% |
| 2018 Q1 | 258.99 Billion KRW | 5.44% |
| 2018 Q2 | 267.68 Billion KRW | 3.35% |
| 2018 Q3 | 276.47 Billion KRW | 3.28% |
| 2018 Q4 | 273.38 Billion KRW | -1.12% |
| 2017 Q1 | 246.91 Billion KRW | -1.69% |
| 2017 FY | 245.62 Billion KRW | -2.2% |
| 2017 Q4 | 245.62 Billion KRW | -1.01% |
| 2017 Q3 | 248.12 Billion KRW | -0.31% |
| 2017 Q2 | 248.88 Billion KRW | 0.8% |
| 2016 FY | 251.16 Billion KRW | -0.57% |
| 2016 Q4 | 251.16 Billion KRW | 7.4% |
| 2016 Q2 | 248.44 Billion KRW | 0.38% |
| 2016 Q3 | 233.85 Billion KRW | -5.87% |
| 2016 Q1 | 247.51 Billion KRW | -2.01% |
| 2015 Q3 | 253.03 Billion KRW | 1.73% |
| 2015 Q4 | 252.59 Billion KRW | -0.18% |
| 2015 FY | 252.59 Billion KRW | 14.11% |
| 2015 Q2 | 248.74 Billion KRW | 12.38% |
| 2015 Q1 | 221.33 Billion KRW | -0.01% |
| 2014 Q2 | 223.88 Billion KRW | 0.25% |
| 2014 Q1 | 223.32 Billion KRW | 4.21% |
| 2014 Q3 | 231.64 Billion KRW | 3.47% |
| 2014 FY | 221.35 Billion KRW | 3.3% |
| 2014 Q4 | 221.35 Billion KRW | -4.44% |
| 2013 FY | 214.29 Billion KRW | -6.56% |
| 2013 Q4 | 214.29 Billion KRW | 0.19% |
| 2013 Q3 | 213.89 Billion KRW | -15.86% |
| 2013 Q2 | 254.21 Billion KRW | 3.96% |
| 2013 Q1 | 244.53 Billion KRW | 6.62% |
| 2012 Q1 | 171.63 Billion KRW | 0.0% |
| 2012 Q4 | 229.34 Billion KRW | 0.0% |
| 2012 FY | 229.34 Billion KRW | 15.74% |
| 2011 FY | 198.15 Billion KRW | 51.22% |
| 2011 Q3 | 128.73 Billion KRW | 9.49% |
| 2011 Q2 | 117.57 Billion KRW | 34.52% |
| 2011 Q1 | 87.4 Billion KRW | 0.0% |
| 2010 Q1 | 41.01 Billion KRW | 0.0% |
| 2010 Q3 | 57.96 Billion KRW | 6.76% |
| 2010 FY | 131.03 Billion KRW | 34.04% |
| 2010 Q2 | 54.29 Billion KRW | 32.4% |
| 2009 FY | 97.76 Billion KRW | -4.98% |
| 2009 Q3 | 43.73 Billion KRW | 13.63% |
| 2009 Q2 | 38.48 Billion KRW | -3.75% |
| 2009 Q1 | 39.98 Billion KRW | 0.0% |
| 2008 Q1 | 49.77 Billion KRW | 0.0% |
| 2008 FY | 102.88 Billion KRW | 42.52% |
| 2008 Q2 | 31.45 Billion KRW | -36.8% |
| 2008 Q3 | 36.06 Billion KRW | 14.64% |
| 2007 Q3 | 37.4 Billion KRW | -0.04% |
| 2007 Q1 | 36.42 Billion KRW | 0.0% |
| 2007 FY | 72.19 Billion KRW | 0.0% |
| 2007 Q2 | 37.41 Billion KRW | 2.71% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dongwha Pharm.Co.,Ltd | 48.25 Billion KRW | -869.543% |
| Yuhan Corporation | 230.07 Billion KRW | -103.353% |
| Yuhan Corporation | 230.07 Billion KRW | -103.353% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1087.238% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1087.238% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1087.238% |
| Ildong Holdings Co., Ltd. | 382.06 Billion KRW | -22.456% |
| Samil Pharmaceutical Co.,Ltd | 175.87 Billion KRW | -166.01% |
| Dong-A Socio Holdings Co., Ltd. | 691.88 Billion KRW | 32.379% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -174.757% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -174.757% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -174.757% |
| SAMSUNG PHARM. Co., LTD. | 595.48 Million KRW | -78467.223% |
| Chong Kun Dang Holdings Corp. | 468.03 Billion KRW | 0.038% |
| Dong Sung Bio Pharm.Co.,Ltd. | 43.27 Billion KRW | -981.179% |
| HANDOK Inc. | 300.01 Billion KRW | -55.947% |
| Jeil Pharma Holdings Inc | 173.03 Billion KRW | -170.39% |
| Kukje Pharma Co., Ltd. | 30.66 Billion KRW | -1425.847% |
| Bukwang Pharmaceutical Co., Ltd. | 79.38 Billion KRW | -489.337% |
| Aprogen pharmaceuticals,Inc. | 180.99 Billion KRW | -158.488% |
| Ilsung Pharmaceuticals Co., Ltd. | 238.12 Million KRW | -196374.395% |
| Daewon Pharmaceutical Co., Ltd. | 146.04 Billion KRW | -220.341% |
| Yungjin Pharm. Co., Ltd. | 66.88 Billion KRW | -599.525% |
| Boryung Corporation | 204.21 Billion KRW | -129.099% |
| Hyundai Pharmaceutical Co., Ltd. | 39.2 Billion KRW | -1093.362% |
| Samjin Pharmaceuticals Co., Ltd. | 118.63 Billion KRW | -294.355% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -449.386% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -449.386% |
| Kwang Dong Pharmaceutical Co., Ltd. | 235.64 Billion KRW | -98.546% |
| Hanall Biopharma Co.,Ltd | 1.29 Billion KRW | -36153.068% |
| Whan In Pharm Co.,Ltd. | 632.02 Million KRW | -73924.956% |
| MYUNGMOON Pharm co.,Ltd | 90.48 Billion KRW | -417.07% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -913.742% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -913.742% |
| Korea United Pharm Inc. | 40.33 Billion KRW | -1059.811% |
| CKD Bio Corp. | 146.92 Billion KRW | -218.429% |
| Daewoong pharmaceutical Co.,Ltd | 469.68 Billion KRW | 0.389% |
| JW Holdings Corporation | 554.58 Billion KRW | 15.639% |
| REYON Pharmaceutical Co., Ltd. | 225.05 Billion KRW | -107.887% |
| Hanmi Pharm. Co., Ltd. | 572.86 Billion KRW | 18.331% |
| Dong-A ST Co., Ltd. | 406.7 Billion KRW | -15.036% |
| Chong Kun Dang Pharmaceutical Corp. | 219.76 Billion KRW | -112.891% |
| JW Lifescience Corporation | 46.31 Billion KRW | -910.21% |
| Ildong Pharmaceutical Co., Ltd. | 217.84 Billion KRW | -114.77% |
| Jeil Pharmaceutical Co.,Ltd | 84.96 Billion KRW | -450.642% |
| Hana Pharm Co., Ltd. | 26.53 Billion KRW | -1663.296% |